Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer.

MLA

Freytag, Svend O., et al. “Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 89, no. 2, June 2014, pp. 268–76. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2014.02.034.

APA

Freytag, S. O., Stricker, H., Lu, M., Elshaikh, M., Aref, I., Pradhan, D., Levin, K., Kim, J. H., Peabody, J., Siddiqui, F., Barton, K., Pegg, J., Zhang, Y., Cheng, J., Oja-Tebbe, N., Bourgeois, R., Gupta, N., Lane, Z., Rodriguez, R., & DeWeese, T. (2014). Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics, 89(2), 268–276. https://doi.org/10.1016/j.ijrobp.2014.02.034

Chicago

Freytag, Svend O., Hans Stricker, Mei Lu, Mohamed Elshaikh, Ibrahim Aref, Deepak Pradhan, Kenneth Levin, et al. 2014. “Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer.” International Journal of Radiation Oncology, Biology, Physics 89 (2): 268–76. doi:10.1016/j.ijrobp.2014.02.034.